These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 10923605)
21. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis. Weiler JM; Meltzer EO Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378 [TBL] [Abstract][Full Text] [Related]
22. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways. Greiff L; Andersson M; Svensson C; Persson CG Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Lumry W; Prenner B; Corren J; Wheeler W Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331 [TBL] [Abstract][Full Text] [Related]
24. Azelastine nasal spray in the management of seasonal allergic rhinitis. Meltzer EO; Weiler JM; Dockhorn RJ; Widlitz MD; Freitag JJ Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778 [TBL] [Abstract][Full Text] [Related]
25. [Clinical assessment of azelastine nasal spray in seasonal allergic rhinitis]. Arcimowicz M; SamoliĆski B; Zawisza E Pol Merkur Lekarski; 1998 Dec; 5(30):363-7. PubMed ID: 10101526 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Hughes K; Glass C; Ripchinski M; Gurevich F; Weaver TE; Lehman E; Fisher LH; Craig TJ Allergy; 2003 May; 58(5):380-5. PubMed ID: 12797340 [TBL] [Abstract][Full Text] [Related]
27. Effects of intranasal azelastine on the response to nasal allergen challenge. Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037 [TBL] [Abstract][Full Text] [Related]
28. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Kalpaklioglu AF; Kavut AB Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317 [TBL] [Abstract][Full Text] [Related]
29. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486 [TBL] [Abstract][Full Text] [Related]
30. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. Craig TJ; Teets S; Lehman EB; Chinchilli VM; Zwillich C J Allergy Clin Immunol; 1998 May; 101(5):633-7. PubMed ID: 9600500 [TBL] [Abstract][Full Text] [Related]
31. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [TBL] [Abstract][Full Text] [Related]
32. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. Storms WW J Allergy Clin Immunol; 2004 Nov; 114(5 Suppl):S146-53. PubMed ID: 15536446 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber. Kyrein HJ; Horak F; Nirnberger G; Rehn D Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281 [TBL] [Abstract][Full Text] [Related]
35. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929 [TBL] [Abstract][Full Text] [Related]
36. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Bernstein JA Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160 [TBL] [Abstract][Full Text] [Related]
37. The role of pseudoephedrine on daytime somnolence in patients suffering from perennial allergic rhinitis (PAR). Sherkat AA; Sardana N; Safaee S; Lehman EB; Craig TJ Ann Allergy Asthma Immunol; 2011 Feb; 106(2):97-102. PubMed ID: 21277510 [TBL] [Abstract][Full Text] [Related]
38. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score. Sardana N; Santos C; Lehman E; Craig T Allergy Asthma Proc; 2010; 31(1):5-9. PubMed ID: 20167140 [TBL] [Abstract][Full Text] [Related]
39. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis. Gastpar H; Dorow P; Aurich R; Petzold U Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660 [TBL] [Abstract][Full Text] [Related]
40. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Woods L; Craig TJ Curr Opin Pulm Med; 2006 Nov; 12(6):390-6. PubMed ID: 17053486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]